Published in Brain Res on June 21, 2005
Molecular targets for antiepileptic drug development. Neurotherapeutics (2007) 1.78
Brain slices as models for neurodegenerative disease and screening platforms to identify novel therapeutics. Curr Neuropharmacol (2007) 1.44
NF-kappaB/Rel regulates inhibitory and excitatory neuronal function and synaptic plasticity. Mol Cell Biol (2006) 1.20
New in vitro phenotypic assay for epilepsy: fluorescent measurement of synchronized neuronal calcium oscillations. PLoS One (2014) 0.76
Brain slices as models for neurodegenerative disease and screening platforms to identify novel therapeutics. Curr Neuropharmacol (2007) 1.44
A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits. Pharmacol Ther (2009) 1.31
Two N-terminal domains of Kv4 K(+) channels regulate binding to and modulation by KChIP1. Neuron (2004) 1.30
Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']di pyrrole-1(2H)-carboxamide). J Pharmacol Exp Ther (2008) 1.07
Amiloride is neuroprotective in an MPTP model of Parkinson's disease. Neurobiol Dis (2008) 1.07
Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research. Biochem Pharmacol (2010) 1.02
The role of calsenilin/DREAM/KChIP3 in contextual fear conditioning. Learn Mem (2009) 1.00
Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition. Sci Transl Med (2013) 0.98
Direct inhibition of Ih by analgesic loperamide in rat DRG neurons. J Neurophysiol (2007) 0.91
Quantitative electroencephalography within sleep/wake states differentiates GABAA modulators eszopiclone and zolpidem from dual orexin receptor antagonists in rats. Neuropsychopharmacology (2013) 0.89
Disruption of Kv1.1 N-type inactivation by novel small molecule inhibitors (disinactivators). Bioorg Med Chem (2007) 0.85
Novel pharmacological activity of loperamide and CP-339,818 on human HCN channels characterized with an automated electrophysiology assay. Eur J Pharmacol (2007) 0.80
Genetic and functional analysis of human P2X5 reveals a distinct pattern of exon 10 polymorphism with predominant expression of the nonfunctional receptor isoform. Mol Pharmacol (2010) 0.79
Validation of DRG-like F11 cells for evaluation of KCNQ/M-channel modulators. Assay Drug Dev Technol (2006) 0.79
Validation of a medium-throughput electrophysiological assay for KCNQ2/3 channel enhancers using IonWorks HT. J Biomol Screen (2007) 0.77
Development of a novel automated ion channel recording method using "inside-out" whole-cell membranes. J Biomol Screen (2005) 0.75
A novel high-throughput screening assay for HCN channel blocker using membrane potential-sensitive dye and FLIPR. J Biomol Screen (2009) 0.75
Ion channel screening plates: design, construction, and maintenance. Assay Drug Dev Technol (2010) 0.75